Novo Nordisk
NVO
NVO
1,375 hedge funds and large institutions have $16B invested in Novo Nordisk in 2025 Q4 according to their latest regulatory filings, with 208 funds opening new positions, 437 increasing their positions, 560 reducing their positions, and 180 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
1% less funds holding
Funds holding: 1,390 → 1,375 (-15)
22% less repeat investments, than reductions
Existing positions increased: 437 | Existing positions reduced: 560
38% less call options, than puts
Call options by funds: $2.02B | Put options by funds: $3.25B
Holders
1,375
Holding in Top 10
19
Calls
$2.02B
Puts
$3.25B
Top Buyers
| 1 | +$247M | |
| 2 | +$220M | |
| 3 | +$219M | |
| 4 |
Goldman Sachs
New York
|
+$218M |
| 5 |
Millennium Management
New York
|
+$81.4M |
Top Sellers
| 1 | -$333M | |
| 2 | -$208M | |
| 3 | -$159M | |
| 4 |
JP Morgan Chase
New York
|
-$95.9M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$78.5M |
